Company Name : Minapharm Pharmaceuticals
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
Release from the company concerning the ESG & TCFD Reports for the fiscal year ended on 31/12/2023.

ESG Report (3,612 KB)
TCFD Report (1,845 KB)